/Investor DB

Cota Capital — 2016 Investments

3 investments dated 2016 · listed companies and verified rows first · show all

Cerebras Systemscerebras.aiin𝕏NASDAQ: CBRSDec 2016

Cerebras designs and manufactures wafer-scale AI processors and systems for data centers, enabling high-speed AI training and inference workloads.

AI & Machine LearningDeep TechHardwareSemiconductorsSunnyvale, US

Andrew Feldman(Chief Executive Officer and Co-Founder)inGary Lauterbach(Chief Technology Officer, Emeritus and Co-founder)inMichael James(Chief Architect, Advanced Technologies and Co-Founder)inSean Lie(CTO and Co-Founder)inJean-Philippe Fricker(Chief System Architect and Co-Founder)in

Co-investors2080 VenturesAlpha Wave GlobalArtisanal VenturesAurum Venture PartnersAzure Ventures GroupB Capital+49 more

Berkeley Lightsberkeleylights.comOct 2016 · $95M

Berkeley Lights (now Bruker Cellular Analysis) develops the Beacon optofluidic system for single-cell functional analysis, enabling researchers to profile live single cells to discover therapeutic antibodies, interrogate T cells, identify cell therapies, and accelerate cell line development.

BiotechDeep TechHardwareEmeryville, US

Ming Wu(Director)inIgor Khandros(Executive Officer, Director)

BoardMichael Marks(Director)inLip-Bu Tan Tan(Director)Michael Moritz(Director)inWilliam Davidow(Director)

Co-investorsCelesta CapitalKhosla VenturesLucas Venture GroupOpen Field CapitalShangBay Capital LLCWalden Catalyst+6 more

Medisasmedisas.comin𝕏Dec 2016Defunct

Medisas develops workflow and collaboration software for hospitals, aimed at reducing the time doctors and nurses spend navigating complicated hospital software so they can focus on patient care.

AI & Machine LearningCloud ComputingDigital HealthEnterprise SoftwareHealthtechSaaSSan Francisco, US

Gautam Sivakumar(CEO)inDustin Chang(CTO)Lynne Tye(Frontend Developer Consultant)in

BoardKeith Rabois(Director)in

Co-investorsKhosla VenturesFundersClubY CombinatorACE & CompanyAndreessen HorowitzFCVC+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.